News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
232,438 Results
Type
Article (22113)
Company Profile (14)
Press Release (210311)
Section
Business (64462)
Career Advice (1046)
Deals (11228)
Drug Delivery (40)
Drug Development (44047)
Employer Resources (70)
FDA (6759)
Job Trends (5848)
News (125225)
Policy (12052)
Tag
2024 BioCapital Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (1)
2024 Biotech Bay Standard (3)
2024 Biotech Beach Digital (1)
2024 Biotech Beach Standard (1)
2024 Genetown Standard (1)
Academia (1301)
Accelerated approval (1)
Adcomms (17)
Allergies (39)
Alliances (16287)
ALS (44)
Alzheimer's disease (720)
Antibody-drug conjugate (ADC) (59)
Approvals (6759)
Artificial intelligence (72)
Autoimmune disease (6)
Automation (2)
Bankruptcy (86)
Best Places to Work (4712)
BIOSECURE Act (8)
Biosimilars (50)
Biotechnology (14)
Bladder cancer (25)
Brain cancer (17)
Breast cancer (105)
Cancer (855)
Cardiovascular disease (67)
Career advice (875)
Career pathing (22)
CAR-T (78)
Cell therapy (199)
Cervical cancer (10)
Clinical research (36137)
Collaboration (288)
Compensation (106)
Complete response letters (9)
COVID-19 (1662)
CRISPR (17)
C-suite (61)
Cystic fibrosis (61)
Data (919)
Denatured (4)
Depression (29)
Diabetes (99)
Diagnostics (1951)
Digital health (4)
Diversity (2)
Diversity, equity & inclusion (20)
Drug discovery (39)
Drug pricing (42)
Drug shortages (7)
Duchenne muscular dystrophy (33)
Earnings (27549)
Editorial (21)
Employer branding (8)
Employer resources (64)
Events (32986)
Executive appointments (192)
FDA (7152)
Featured Employer (8)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (2)
Funding (218)
Gene editing (40)
Generative AI (8)
Gene therapy (144)
GLP-1 (371)
Government (2037)
Grass and pollen (2)
Guidances (21)
Healthcare (6967)
Huntington's disease (13)
IgA nephropathy (10)
Immunology and inflammation (50)
Indications (7)
Infectious disease (1721)
Inflammatory bowel disease (63)
Inflation Reduction Act (6)
Influenza (21)
Intellectual property (34)
Interviews (185)
IPO (5023)
IRA (19)
Job creations (1342)
Job search strategy (745)
Kidney cancer (5)
Labor market (9)
Layoffs (266)
Leadership (5)
Legal (2403)
Liver cancer (35)
Lung cancer (142)
Lymphoma (78)
Machine learning (1)
Management (25)
Manufacturing (86)
MASH (37)
Medical device (4153)
Medtech (4153)
Mergers & acquisitions (6334)
Metabolic disorders (283)
Multiple sclerosis (34)
NASH (14)
Neurodegenerative disease (36)
Neuropsychiatric disorders (12)
Neuroscience (946)
NextGen: Class of 2025 (2340)
Non-profit (1717)
Northern California (857)
Now hiring (8)
Obesity (145)
Opinion (135)
Ovarian cancer (28)
Pain (41)
Pancreatic cancer (37)
Parkinson's disease (55)
Partnered (5)
Patents (61)
Patient recruitment (35)
Peanut (21)
People (16447)
Pharmaceutical (8)
Pharmacy benefit managers (5)
Phase I (10317)
Phase II (15881)
Phase III (13339)
Pipeline (442)
Podcasts (24)
Policy (48)
Postmarket research (1327)
Preclinical (3520)
Press Release (17)
Prostate cancer (39)
Psychedelics (22)
Radiopharmaceuticals (98)
Rare diseases (191)
Real estate (1795)
Recruiting (29)
Regulatory (8509)
Reports (5)
Research institute (1097)
Resumes & cover letters (156)
Rett syndrome (1)
RNA editing (1)
RSV (19)
Schizophrenia (41)
Series A (42)
Series B (22)
Service/supplier (1)
Sickle cell disease (31)
Southern California (670)
Special edition (7)
Sponsored (14)
Startups (1406)
Stomach cancer (4)
Supply chain (10)
The Weekly (20)
United States (6939)
Vaccines (422)
Venture capitalists (18)
Webinars (5)
Weight loss (114)
Women's health (11)
Worklife (9)
Date
Today (73)
Last 7 days (336)
Last 30 days (1058)
Last 365 days (13212)
2025 (2006)
2024 (13510)
2023 (15473)
2022 (19075)
2021 (20569)
2020 (19263)
2019 (16924)
2018 (13319)
2017 (12804)
2016 (11928)
2015 (13692)
2014 (9449)
2013 (7188)
2012 (7945)
2011 (8396)
2010 (7110)
Location
Africa (374)
Alabama (13)
Alaska (3)
Arizona (46)
Asia (15405)
Australia (2689)
California (1797)
Canada (610)
China (174)
Colorado (91)
Connecticut (98)
Delaware (52)
Europe (35365)
Florida (244)
Georgia (60)
Idaho (14)
Illinois (140)
India (4)
Indiana (88)
Iowa (2)
Japan (59)
Kansas (46)
Kentucky (3)
Louisiana (1)
Maine (15)
Maryland (239)
Massachusetts (1392)
Michigan (70)
Minnesota (110)
Mississippi (1)
Missouri (13)
Montana (9)
Nebraska (11)
Nevada (14)
New Hampshire (11)
New Jersey (641)
New Mexico (7)
New York (563)
North Carolina (311)
North Dakota (1)
Northern California (857)
Ohio (60)
Oklahoma (5)
Oregon (10)
Pennsylvania (416)
Puerto Rico (2)
Rhode Island (4)
South America (441)
South Carolina (6)
Southern California (670)
Tennessee (20)
Texas (226)
Utah (51)
Virginia (30)
Washington D.C. (17)
Washington State (182)
West Virginia (1)
Wisconsin (9)
232,438 Results for "two pore guys".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Vaccines
Two Years Into Novavax Reset, CEO Jacobs Hunts for Silver Linings
After two years characterized by layoffs, pipeline reorganizations, FDA delays and clinical holds, Novavax CEO John Jacobs says the company is at a pivot point.
January 28, 2025
·
6 min read
·
Annalee Armstrong
Press Releases
MedImpact Expands Access to Two Biosimilars for Stelara
February 27, 2025
·
2 min read
Press Releases
Connect Biopharma to Present at Two Upcoming Investor Conferences
March 3, 2025
·
1 min read
Press Releases
Seaport Therapeutics to Participate in Two Upcoming Investor Conferences
March 3, 2025
·
1 min read
Press Releases
Foghorn Therapeutics to Participate in Two Upcoming Investor Conferences
February 26, 2025
·
1 min read
Press Releases
Aquestive Therapeutics to Participate in Two Upcoming Conferences in March
February 26, 2025
·
3 min read
Press Releases
Frontier Medicines to Participate in Two Upcoming March Investor Conferences
February 27, 2025
·
1 min read
Press Releases
Ocular Therapeutix™ to Present at Two Investor Conferences in March 2025
February 26, 2025
·
1 min read
Press Releases
Dianthus Therapeutics to Participate in Two Upcoming March 2025 Investor Conferences
February 27, 2025
·
1 min read
Press Releases
scPharmaceuticals Announces Participation in Two Upcoming March 2025 Investor Conferences
February 27, 2025
·
1 min read
1 of 23,244
Next
